Publication | Closed Access
Inhibition of angiogenesis: Thalidomide or low-molecular-weight heparin? Authors' reply
17
Citations
0
References
2005
Year
ThrombosisAngiogenesisHematologyPharmacologyHemostasisVascular BiologyPharmacotherapyNeovascularizationMedicineAtherosclerosisHeparinsLow-molecular-weight Heparin
No additional data available for this publication yet. Check back later!